Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-07-002535
Filing Date
2007-05-31
Accepted
2007-05-31 17:20:15
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d72077_10-k.htm 10-K 2373867
2 AMENDED AND RESTATED 1996 STOCK OPTION PLAN d72077_ex10-4.htm EX-10.4 79554
3 SUBSIDIARIES OF THE REGISTRANT d72077_ex21-1.htm EX-21.1 1707
4 CERTIFICATIONS d72077_ex31-1.htm EX-31.1 8924
5 CERTIFICATIONS d72077_ex31-2.htm EX-31.2 9014
6 CERTIFICATIONS d72077_ex32-1.htm EX-32.1 3787
7 CELLTRION, INC. FINANCIAL STATEMENTS d72077_ex99-2.htm EX-99.2 752033
  Complete submission text file 0001169232-07-002535.txt   3230291
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 6506241000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26483 | Film No.: 07891724
SIC: 2834 Pharmaceutical Preparations